The American Society for Transplantation and Cellular Therapy (ASTCT) is an international professional membership association of more than 3,000 physicians, investigators, and other healthcare professionals from more than 45 countries. Our mission is dedicated to improving the application and success of blood and marrow transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field. Learn more at astct.org.
Plant-Based Diet, Butyrate Production “Associated With Sustained MRD Negativity in Multiple MyelomaJanuary 3rd 2023
ASTCT recently published an article by Eleanor Mayfield, ELS, in their journal Nucleus discussing minimal residual disease negativity in patients with multiple myeloma.
Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescentsNovember 23rd 2022
ASTCT recently published an article in their journal Nucleus discussing extracorporeal photopheresis compared with acute graft-versus-host disease after receipt of hematopoietic stem cell transplant in children or young adults.
Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host diseaseNovember 23rd 2022
ASTCT recently published an article in their journal Nucleus detailing the use of mesenchymal stromal cells for the treatment of graft-versus-host disease
KIR-ligand Mismatch in CBT Outcomes Differ Based on GVHD ProphylaxesNovember 22nd 2021
ASTCT recently published an article in their journal Nucleus detailing the use of killer immunoglobulin-like receptor–ligand mismatch and its impact on graft versus host disease.
Factors Affecting Tacrolimus Concentrations in Children with β-Thalassemia Major receiving HSCTNovember 15th 2021
ASTCT recently published an article in their journal Nucleus detailing the impact of genotype and voriconazole co-administration on tacrolimus trough concentration in pediatric β-thalassemia major patients following allogeneic hematopoietic stem cell transplantation.
Chinese Researchers Identify Risk Factors for Poor Treatment Response to CAR T Therapy in ALL PatientsOctober 25th 2021
ASTCT recently published an article in their journal Nucleus detailing CAR T therapy in patients with acute lymphoblastic leukemia.
Rapamycin Pre-Treatment of CAR T Cells “May Enhance Therapeutic Efficacy Against AML”October 4th 2021
A recently published article on CAR T cells in patients with acute myeloid leukemia is featured by CancerNetwork's Strategic Alliance Partner ASTCT.
Outpatient Haploidentical Stem Cell TransplantationSeptember 14th 2021
The latest episode of the ASTCT Talks episode features a discussion from Andrés Gómez De León, MD, and Perla Colunga, MD, on outpatient haploidentical stem cell transplantation.
Effective T-Cell Immunity Against Various Coronaviruses Is Possible in Stem Cell Transplant RecipientsFebruary 9th 2021
Findings from a poster presentation at the 2021 Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR suggest the feasibility of successful vaccinations against coronaviruses in patients with hematologic malignancies following stem cell transplant.